New Science Ventures

Summary

In 2004 was created New Science Ventures, which is appeared as VC. The main office of represented VC is situated in the New York. The company was established in North America in United States.

The fund was created by Somu Subramaniam. We also calculated 8 valuable employees in our database.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Light Sciences Oncology, BioVex, Juventas Therapeutics We can highlight the next thriving fund investment areas, such as Medical Device, Pharmaceutical. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

Considering the real fund results, this VC is 16 percentage points more often commits exit comparing to other organizations. The fund is generally included in 2-6 deals every year. Deals in the range of 10 - 50 millions dollars are the general things for fund. Comparing to the other companies, this New Science Ventures performs on 10 percentage points less the average number of lead investments. The top amount of exits for fund were in 2015. The important activity for fund was in 2016. Despite it in 2019 the fund had an activity.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the New Science Ventures, startups are often financed by Oxford Bioscience Partners, Easton Capital, Triathlon Medical Venture Partners. The meaningful sponsors for the fund in investment in the same round are Forbion Capital Partners, Easton Capital, Triathlon Medical Venture Partners. In the next rounds fund is usually obtained by Easton Capital, Oxford Bioscience Partners, OrbiMed.